Clinical Trials
37 trialsIMMULAB - Immunotherapy With Pembrolizumab in Combination With Local Ablation in Hepatocellular Carcinoma (HCC)
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
SM-OCT-01
Seoul National University Hospital
RFA Versus SBRT for Recurrent Small HCC
Sun Yat-sen University
Cytokine Change in Hepatocellular Carcinoma Treated by Thermal Ablation
Chinese University of Hong Kong
Stereotactic Body Radiotherapy Versus Radiofrequency Ablation for Unresectable, Small (≤ 3 cm) HCC
Asan Medical Center
A Pilot Study of Combined Immune Checkpoint Inhibition in Combination With Ablative Therapies in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC)
National Institutes of Health Clinical Center (CC)
Anatomical Radiofrequency Ablation for Small Hepatocellular Carcinoma
Seoul National University Hospital
Laparoscopic Hepatectomy and Radiofrequency Ablation in the Treatment of Early Hepatocellular Carcinoma
Southwest Hospital, China
Effectiveness of Microwave Ablation of Hepatocellular Carcinoma as Compared to Radiofrequency Ablation
Chinese University of Hong Kong
HR-HCC/PHT
Guangxi Medical University
Radiofrequency Ablation Plus Radiotherapy for Small Hepatocellular Carcinoma
Guangxi Medical University
RFA vs. SBRT for Small HCC
Sun Yat-sen University
ACRIN-6673
American College of Radiology Imaging Network
ARTC-HCC
Guangxi Medical University
RFA Plus Carrizumab vs Carrizumab Alone for HCC
Second Affiliated Hospital, School of Medicine, Zhejiang University
SAIL
Sun Yat-sen University
ARMTICH
Assistance Publique - Hôpitaux de Paris
Combined Radiotherapy and Radiofrequency Ablation for Hepatocellular Carcinoma
Guangxi Medical University
Tremelimumab With Chemoembolization or Ablation for Liver Cancer
National Institutes of Health Clinical Center (CC)
QPEAvsRFA
Sun Yat-sen University
The Effect of Viral Load on Intrahepatic Recurrence in Hepatitis B Virus (HBV)-Related Hepatocellular Carcinoma (HCC)
Seoul National University Hospital
Heat Therapy in Treating Patients With Unresectable Primary or Metastatic Liver Cancer
M.D. Anderson Cancer Center
TACE+RFA
Fudan University
ARMCENVIN
Assistance Publique - Hôpitaux de Paris
Radiofrequency Ablation in Treating Patients With Unresectable Primary or Metastatic Liver Cancer
National Institutes of Health Clinical Center (CC)
TACE Combined With Synchronous Radiofrequency /Microwave Ablation to Treat Large and Huge Hepatocellular Carcinoma
Shanghai Zhongshan Hospital
Proton Radiotherapy Versus Radiofrequency Ablation for Patients With Medium or Large Hepatocellular Carcinoma
Chang Gung Memorial Hospital
Hepatic Resection Versus TACE+RFA for BCLC Stage B Hepatocellular Carcinoma
First Affiliated Hospital, Sun Yat-Sen University
Comparison of Microwave and Radiofrequency Ablation for Liver
Chinese PLA General Hospital
A Study Comparing Radiofrequency Ablation and Hepatic Resection for Hepatocellular Carcinoma
Seoul National University Hospital
Radiofrequency Ablation in Treating Patients With Liver Cancer (Hepatocellular Carcinoma)
Washington University School of Medicine
Combine TACE and RFA Versus RFA Monotherapy in Unilobar HCC of 3.1 to 7 cm Patient
Chang Gung Memorial Hospital
Hepatocellular Carcinoma Treated With Iodine-125 Implantation
The Second People's Hospital of GuangDong Province
Heat Activated Liposomal Doxorubicin and Radiofrequency Ablation in Treating Patients With Primary or Metastatic Liver Tumors
National Institutes of Health Clinical Center (CC)
Arabinoxylan Rice Bran (MGN-3/Biobran) for the Treatment of Hepatocellular Carcinoma and Hepatitis B and C Infection
The 108 Military Central Hospital
RFA and TACE
Sun Yat-sen University
TACE-RFA
Sun Yat-sen University